AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 18056556 — intervention group
Group type: EXPERIMENTAL
Intervention: Single‐session communication intervention (one 2 1/2‐hour session)
Number of subjects: 1115
Study 18056556 — intervention group
Group type: COMPARATOR
Intervention: General health intervention (control, one 2 1/2‐hour session)
Number of subjects: 1115
Study 16681100 — intervention group
Group type: EXPERIMENTAL
Intervention: Medical and surgical preventive measures for thromboembolic disease
Number of subjects: 0
Study 16681100 — intervention group
Group type: COMPARATOR
Intervention: Old concept of thromboembolic prophylaxis
Number of subjects: 0
Study 11273995 — intervention group
Group type: EXPERIMENTAL
Intervention: Repaired tetralogy of Fallot patients (TOF)
Number of subjects: 74
Study 11273995 — intervention group
Group type: COMPARATOR
Intervention: Normal control subjects
Number of subjects: 74
Study 9385891 — intervention group
Group type: EXPERIMENTAL
Intervention: Treadmill exercise echocardiography
Number of subjects: 85
Study 9385891 — intervention group
Group type: COMPARATOR
Intervention: Dobutamine stress echocardiography
Number of subjects: 85
Study 9385891 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine stress echocardiography with atropine
Number of subjects: 85
Study 9385891 — intervention group
Group type: EXPERIMENTAL
Intervention: Dobutamine infusion
Number of subjects: 85
Study 9385891 — intervention group
Group type: COMPARATOR
Intervention: Treadmill exercise
Number of subjects: 85
Study 8205252 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of lipiodol (0.5 ml) 1-3 months before conception (Group A)
Number of subjects: 4
Study 8205252 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of lipiodol (0.5 ml) during the first month of pregnancy (Group B)
Number of subjects: 4
Study 8205252 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral administration of lipiodol (0.5 ml) during the third month of pregnancy (Group C)
Number of subjects: 4
Study 8205252 — intervention group
Group type: COMPARATOR
Intervention: Untreated group (Group D)
Number of subjects: 4
Study 3297121 — intervention group
Group type: EXPERIMENTAL
Intervention: Amiodarone (200 mg/day)
Number of subjects: 22
Study 3297121 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 22
Study 2252196 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical 1% hydrocortisone cream
Number of subjects: 40
Study 2252196 — intervention group
Group type: COMPARATOR
Intervention: KY jelly
Number of subjects: 40
Study 1090905 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy sessions led by two nurses, twice a week for 20 sessions
Number of subjects: 100
Study 1090905 — intervention group
Group type: COMPARATOR
Intervention: Control group (no group therapy)
Number of subjects: 100
Study 1090905 — intervention group
Group type: EXPERIMENTAL
Intervention: Group therapy sessions
Number of subjects: 100
Study 31801563 — intervention group
Group type: EXPERIMENTAL
Intervention: Biannual mass azithromycin distribution
Number of subjects: 0
Study 31801563 — intervention group
Group type: EXPERIMENTAL
Intervention: Single orally administered dose of azithromycin
Number of subjects: 0
Study 31801563 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 28489321 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine patch (21 mg)
Number of subjects: 25
Study 28489321 — intervention group
Group type: COMPARATOR
Intervention: Placebo patch
Number of subjects: 25
Study 26352697 — intervention group
Group type: EXPERIMENTAL
Intervention: Rural community-based integrated intervention including systematic health education, smoking cessation counseling, and education on management of COPD.
Number of subjects: 1008
Study 26352697 — intervention group
Group type: COMPARATOR
Intervention: Usual care (control group).
Number of subjects: 1008
Study 23025390 — intervention group
Group type: EXPERIMENTAL
Intervention: 5 g of yellow mustard bran
Number of subjects: 10
Study 23025390 — intervention group
Group type: COMPARATOR
Intervention: Potato and leek soup without yellow mustard bran
Number of subjects: 10
Study 20932157 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-level laser therapy (LLLT) with GaAlAs diode laser, 808 nm wavelength, energy density of 4 J/cm² applied on days 1, 2, and 7 after periodontal treatment
Number of subjects: 36
Study 20932157 — intervention group
Group type: COMPARATOR
Intervention: Control group (non-surgical periodontal therapy without LLLT)
Number of subjects: 36
Study 20932157 — intervention group
Group type: EXPERIMENTAL
Intervention: LLLT group (smokers)
Number of subjects: 36
Study 20932157 — intervention group
Group type: COMPARATOR
Intervention: Both groups (LLLT and control)
Number of subjects: 36
Study 19535691 — intervention group
Group type: EXPERIMENTAL
Intervention: Epsilon-aminocaproic acid (EACA)
Number of subjects: 78
Study 19535691 — intervention group
Group type: EXPERIMENTAL
Intervention: Aprotinin
Number of subjects: 78
Study 19535691 — intervention group
Group type: COMPARATOR
Intervention: Saline (placebo)
Number of subjects: 78
Study 16926245 — intervention group
Group type: EXPERIMENTAL
Intervention: Testosterone (T) gel therapy, 50 mg/d for 6 months
Number of subjects: 35
Study 16926245 — intervention group
Group type: COMPARATOR
Intervention: Control group (age-matched controls)
Number of subjects: 35
Study 15624399 — intervention group
Group type: EXPERIMENTAL
Intervention: Surgical treatment of varicocele
Number of subjects: 0
Study 15624399 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 11701677 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone patch plus oral desogestrel (300 microg/d)
Number of subjects: 23
Study 11701677 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone patch plus oral desogestrel (150 microg/d)
Number of subjects: 23
Study 11701677 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone patch plus oral desogestrel (75 microg/d)
Number of subjects: 23
Study 11701677 — intervention group
Group type: EXPERIMENTAL
Intervention: Transdermal testosterone patch plus oral desogestrel (various doses)
Number of subjects: 23
Study 9385486 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP) 750 mg BID for 10 days
Number of subjects: 743
Study 9385486 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin (CLR) 500 mg BID for 10 days
Number of subjects: 743
Study 9385486 — intervention group
Group type: EXPERIMENTAL
Intervention: Ciprofloxacin (CIP)
Number of subjects: 743
Study 9385486 — intervention group
Group type: COMPARATOR
Intervention: Clarithromycin (CLR)
Number of subjects: 743
Study 8201718 — intervention group
Group type: EXPERIMENTAL
Intervention: Angioscopically assisted valve lysis and vein branch identification (scope)
Number of subjects: 59
Study 8201718 — intervention group
Group type: COMPARATOR
Intervention: No angioscopy (no scope)
Number of subjects: 59
Study 3034221 — intervention group
Group type: EXPERIMENTAL
Intervention: oral metyrapone tartrate
Number of subjects: 14
Study 3034221 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 14
Study 29903847 — intervention group
Group type: EXPERIMENTAL
Intervention: Liraglutide
Number of subjects: 9340
Study 29903847 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 9340
Study 29903847 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined analysis (liraglutide and placebo)
Number of subjects: 9340
Study 28646216 — intervention group
Group type: EXPERIMENTAL
Intervention: Naftopidil 75 mg once daily
Number of subjects: 100
Study 28646216 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 100
Study 25310567 — intervention group
Group type: EXPERIMENTAL
Intervention: Image capture method for knee joint-position-sense measurement
Number of subjects: 10
Study 25310567 — intervention group
Group type: COMPARATOR
Intervention: Isokinetic dynamometer (IKD) method for knee joint-position-sense measurement
Number of subjects: 10
Study 23208521 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.125%) alone
Number of subjects: 40
Study 23208521 — intervention group
Group type: EXPERIMENTAL
Intervention: Epidural bupivacaine (0.125%) with fentanyl (2 µg/ml)
Number of subjects: 40
Study 20955511 — intervention group
Group type: EXPERIMENTAL
Intervention: Laparoscopic surgery
Number of subjects: 97
Study 20955511 — intervention group
Group type: COMPARATOR
Intervention: Open surgery
Number of subjects: 97
Study 19568711 — intervention group
Group type: EXPERIMENTAL
Intervention: Artequick (administered twice in 24 h)
Number of subjects: 103
Study 19568711 — intervention group
Group type: COMPARATOR
Intervention: Artekin (administered 4 times in 2 days)
Number of subjects: 103
Study 16764182 — intervention group
Group type: EXPERIMENTAL
Intervention: Patient-controlled regional anesthesia device (Pain Care 2000; Breg, Inc, Vista, Calif)
Number of subjects: 41
Study 14769577 — intervention group
Group type: EXPERIMENTAL
Intervention: Total or near-total thyroidectomy (group 1; n = 109)
Number of subjects: 218
Study 14769577 — intervention group
Group type: COMPARATOR
Intervention: Bilateral subtotal thyroidectomy (group 2; n = 109)
Number of subjects: 218
Study 11882452 — intervention group
Group type: EXPERIMENTAL
Intervention: Transmyocardial revascularization with CO(2) laser in addition to medical treatment
Number of subjects: 100
Study 11882452 — intervention group
Group type: COMPARATOR
Intervention: Continued optimal medical treatment
Number of subjects: 100
Study 9089559 — intervention group
Group type: EXPERIMENTAL
Intervention: Estradiol-releasing vaginal ring with a 100 mg vaginal progesterone suppository (7 days every month)
Number of subjects: 56
Study 9089559 — intervention group
Group type: COMPARATOR
Intervention: Transdermal daily dose of 50 micrograms of estradiol with a levonorgestrel-releasing intrauterine device
Number of subjects: 56
Study 8185744 — intervention group
Group type: EXPERIMENTAL
Intervention: TENS group (n = 19)
Number of subjects: 38
Study 8185744 — intervention group
Group type: COMPARATOR
Intervention: Control group (n = 19)
Number of subjects: 38
Study 3131040 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous infusion of 100 mg recombinant tissue-type plasminogen activator (rt-PA) over 3 hours
Number of subjects: 145
Study 3131040 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 145
Study 31277796 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal aflibercept 2 mg every 4 weeks
Number of subjects: 366
Study 31277796 — intervention group
Group type: COMPARATOR
Intervention: Sham injections
Number of subjects: 366
Study 28007457 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular-targeted photodynamic therapy (4 mg/kg padeliporfin intravenously over 10 min, laser activation for 22 min 15 s)
Number of subjects: 413
Study 28007457 — intervention group
Group type: COMPARATOR
Intervention: Active surveillance
Number of subjects: 413
Study 28007457 — intervention group
Group type: EXPERIMENTAL
Intervention: Vascular-targeted photodynamic therapy
Number of subjects: 413
Study 24824304 — intervention group
Group type: EXPERIMENTAL
Intervention: Manual root planing with a curette
Number of subjects: 19
Study 24824304 — intervention group
Group type: EXPERIMENTAL
Intervention: Piezoelectric ultrasonic (PU) scraper
Number of subjects: 19
Study 24824304 — intervention group
Group type: EXPERIMENTAL
Intervention: Vertically oscillating ultrasonic (VOU) scraper
Number of subjects: 19
Study 24824304 — intervention group
Group type: COMPARATOR
Intervention: No treatment
Number of subjects: 19
Study 24005276 — intervention group
Group type: EXPERIMENTAL
Intervention: Original septal stent with integrated electrode
Number of subjects: 102
Study 24005276 — intervention group
Group type: COMPARATOR
Intervention: Standard treatment (control group)
Number of subjects: 102
Study 21272972 — intervention group
Group type: EXPERIMENTAL
Intervention: 2-mm locking titanium miniplates
Number of subjects: 20
Study 21272972 — intervention group
Group type: COMPARATOR
Intervention: 2-mm standard nonlocking titanium miniplates
Number of subjects: 20
Study 19849726 — intervention group
Group type: EXPERIMENTAL
Intervention: Hibiscus Abelmoschus seed extract (Linefactor)
Number of subjects: 0
Study 16821183 — intervention group
Group type: EXPERIMENTAL
Intervention: Simplified palpation method
Number of subjects: 72
Study 16821183 — intervention group
Group type: COMPARATOR
Intervention: Recommended palpation method
Number of subjects: 72
Study 12767646 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium 40 microg three times a day with meals (n = 385)
Number of subjects: 897
Study 12767646 — intervention group
Group type: COMPARATOR
Intervention: Placebo (n = 377)
Number of subjects: 897
Study 12767646 — intervention group
Group type: EXPERIMENTAL
Intervention: Beraprost sodium
Number of subjects: 897
Study 12767646 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 897
Study 10831641 — intervention group
Group type: EXPERIMENTAL
Intervention: rhGH (0.2 IU/kg/day subcutaneously)
Number of subjects: 17
Study 9380445 — intervention group
Group type: EXPERIMENTAL
Intervention: LCP-enriched preterm formula
Number of subjects: 30
Study 9380445 — intervention group
Group type: COMPARATOR
Intervention: Standard preterm formula
Number of subjects: 30
Study 9380445 — intervention group
Group type: COMPARATOR
Intervention: Breast milk
Number of subjects: 30
Study 1575571 — intervention group
Group type: EXPERIMENTAL
Intervention: Allergen free diet
Number of subjects: 94
Study 1575571 — intervention group
Group type: COMPARATOR
Intervention: Allergen restricted diet (containing only lactoproteins and yellow dyes)
Number of subjects: 94
Study 2857901 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous bolus of 100 micrograms human alpha‐ANP
Number of subjects: 6
Study 2857901 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 6
Study 31488242 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluative conditioning (EC) procedure using positive social feedback
Number of subjects: 129
Study 31488242 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 129
Study 31488242 — intervention group
Group type: EXPERIMENTAL
Intervention: Evaluative conditioning (EC) procedure
Number of subjects: 129
Study 29529938 — intervention group
Group type: EXPERIMENTAL
Intervention: Pleasant stimulus (PS)
Number of subjects: 20
Study 29529938 — intervention group
Group type: EXPERIMENTAL
Intervention: Unpleasant stimulus (US)
Number of subjects: 20
Study 29529938 — intervention group
Group type: COMPARATOR
Intervention: Neutral stimulus (NS)
Number of subjects: 20
Study 25895494 — intervention group
Group type: EXPERIMENTAL
Intervention: Family Startup Program (FSP)
Number of subjects: 2500
Study 25895494 — intervention group
Group type: COMPARATOR
Intervention: Treatment As Usual (TAU)
Number of subjects: 2500
Study 24279747 — intervention group
Group type: EXPERIMENTAL
Intervention: Intradialytic progressive exercise training (using an adapted cycle ergometer)
Number of subjects: 50
Study 24279747 — intervention group
Group type: COMPARATOR
Intervention: Control group (no exercise intervention)
Number of subjects: 50
Study 21544074 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravenous acetaminophen 1,000 mg
Number of subjects: 60
Study 21544074 — intervention group
Group type: COMPARATOR
Intervention: Intravenous placebo
Number of subjects: 60
Study 19033545 — intervention group
Group type: EXPERIMENTAL
Intervention: Endurance exercise (EE) for 6 months
Number of subjects: 0
Study 17288697 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled insulin (HIIP; AIR inhaled insulin)
Number of subjects: 137
Study 17288697 — intervention group
Group type: COMPARATOR
Intervention: Subcutaneous insulin (regular human insulin or insulin lispro)
Number of subjects: 137
Study 15337620 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard aspirin and dipyridamole treatment b.i.d. for 2 weeks
Number of subjects: 57
Study 15337620 — intervention group
Group type: COMPARATOR
Intervention: Titration with aspirin only in the morning and aspirin and dipyridamole in the evening for 5 days, followed by 9 days of standard aspirin and dipyridamole treatment
Number of subjects: 57
Study 11405121 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 9519022 — intervention group
Group type: EXPERIMENTAL
Intervention: Benzocaine spray
Number of subjects: 36
Study 9519022 — intervention group
Group type: COMPARATOR
Intervention: Placebo spray
Number of subjects: 36
Study 9510219 — intervention group
Group type: EXPERIMENTAL
Intervention: Olanzapine (5-20 mg/d)
Number of subjects: 1996
Study 9510219 — intervention group
Group type: COMPARATOR
Intervention: Haloperidol (5-20 mg/d)
Number of subjects: 1996
Study 1894296 — intervention group
Group type: EXPERIMENTAL
Intervention: 8 mg intravenous oxyfedrine
Number of subjects: 18
Study 1894296 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 18
Study 6886353 — intervention group
Group type: EXPERIMENTAL
Intervention: 99mTc-labeled solid-phase meal
Number of subjects: 17
Study 6886353 — intervention group
Group type: COMPARATOR
Intervention: Control subjects
Number of subjects: 17
Study 6886353 — intervention group
Group type: EXPERIMENTAL
Intervention: Patients with gastric stasis
Number of subjects: 17
Study 30966835 — intervention group
Group type: EXPERIMENTAL
Intervention: Dexketoprofen
Number of subjects: 60
Study 30966835 — intervention group
Group type: COMPARATOR
Intervention: Control (no dexketoprofen)
Number of subjects: 60
Study 30726220 — intervention group
Group type: EXPERIMENTAL
Intervention: Recognition of number-one Billboard singles from the last 76 years
Number of subjects: 0
Study 30726220 — intervention group
Group type: EXPERIMENTAL
Intervention: Self-selected exposure to each song as measured by its play count on Spotify
Number of subjects: 0
Study 30198872 — intervention group
Group type: EXPERIMENTAL
Intervention: Rofecoxib (25 mg once daily)
Number of subjects: 351
Study 30198872 — intervention group
Group type: EXPERIMENTAL
Intervention: Naproxen (220 mg twice-daily)
Number of subjects: 351
Study 30198872 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 351
Study 26653681 — intervention group
Group type: EXPERIMENTAL
Intervention: Anticoagulation therapy
Number of subjects: 64
Study 26653681 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 64
Study 24120264 — intervention group
Group type: EXPERIMENTAL
Intervention: Biliopancreatic diversion with duodenal switch (BPD‐DS) surgery
Number of subjects: 73
Study 24120264 — intervention group
Group type: COMPARATOR
Intervention: Control group (severely obese without surgery)
Number of subjects: 73
Study 22260859 — intervention group
Group type: EXPERIMENTAL
Intervention: 2 g of fish oil (1.1 g marine n‐3 PUFA)
Number of subjects: 50
Study 22260859 — intervention group
Group type: COMPARATOR
Intervention: 2 g of olive oil (control)
Number of subjects: 50
Study 20629927 — intervention group
Group type: EXPERIMENTAL
Intervention: Kangaroo holding
Number of subjects: 65
Study 20629927 — intervention group
Group type: EXPERIMENTAL
Intervention: Blanket holding
Number of subjects: 65
Study 20629927 — intervention group
Group type: COMPARATOR
Intervention: Control group (brief social visits, no holding constraints)
Number of subjects: 65
Study 17896065 — intervention group
Group type: EXPERIMENTAL
Intervention: Major trauma (involving perineal muscles or requiring suturing)
Number of subjects: 444
Study 17896065 — intervention group
Group type: COMPARATOR
Intervention: Intact delivery (no trauma)
Number of subjects: 444
Study 17896065 — intervention group
Group type: EXPERIMENTAL
Intervention: Minor trauma
Number of subjects: 444
Study 15372199 — intervention group
Group type: EXPERIMENTAL
Intervention: Lidocaine injection
Number of subjects: 29
Study 15372199 — intervention group
Group type: EXPERIMENTAL
Intervention: Botulinum toxin type A (BTX‐A) injection
Number of subjects: 29
Study 15372199 — intervention group
Group type: COMPARATOR
Intervention: Dry needling
Number of subjects: 29
Study 11920411 — intervention group
Group type: EXPERIMENTAL
Intervention: 30 mg of cevimeline 3 times daily
Number of subjects: 0
Study 11920411 — intervention group
Group type: EXPERIMENTAL
Intervention: 15 mg of cevimeline 3 times daily
Number of subjects: 0
Study 11920411 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 9823079 — intervention group
Group type: EXPERIMENTAL
Intervention: Oscillating/rotating power toothbrush (Braun Oral‐B Ultra Plaque Remover‐D9)
Number of subjects: 62
Study 9823079 — intervention group
Group type: COMPARATOR
Intervention: High frequency toothbrush (sonicare)
Number of subjects: 62
Study 9823079 — intervention group
Group type: EXPERIMENTAL
Intervention: Both toothbrushes
Number of subjects: 62
Study 9823079 — intervention group
Group type: EXPERIMENTAL
Intervention: D9 toothbrush
Number of subjects: 62
Study 7967427 — intervention group
Group type: EXPERIMENTAL
Intervention: 12 Gy fractionated total body irradiation (FTBI) and 2 (or 3) cytotoxic drugs (group A, n = 19)
Number of subjects: 28
Study 7967427 — intervention group
Group type: COMPARATOR
Intervention: 3 cytotoxic drugs (group B, n = 9)
Number of subjects: 28
Study 7967427 — intervention group
Group type: EXPERIMENTAL
Intervention: FTBI-containing regimen
Number of subjects: 28
Study 7967427 — intervention group
Group type: EXPERIMENTAL
Intervention: Overall survival at day +100
Number of subjects: 28
Study 3382233 — intervention group
Group type: EXPERIMENTAL
Intervention: Lentinan
Number of subjects: 0
Study 3382233 — intervention group
Group type: EXPERIMENTAL
Intervention: MMC and FT(MF) with Lentinan
Number of subjects: 0
Study 3382233 — intervention group
Group type: COMPARATOR
Intervention: MMC and FT(MF) without Lentinan
Number of subjects: 0
Study 29226957 — intervention group
Group type: EXPERIMENTAL
Intervention: Focused cardiac ultrasound before surgery
Number of subjects: 100
Study 29226957 — intervention group
Group type: COMPARATOR
Intervention: Control group (no ultrasound)
Number of subjects: 100
Study 28920458 — intervention group
Group type: EXPERIMENTAL
Intervention: Nordic walking (NW)
Number of subjects: 30
Study 28920458 — intervention group
Group type: COMPARATOR
Intervention: Traditional walking training (WT)
Number of subjects: 30
Study 25070546 — intervention group
Group type: EXPERIMENTAL
Intervention: Weekly paclitaxel (wPxl; 80 mg/m(2)/week ×6 with 2‐week break) plus saracatinib (S; 175 mg o.d.)
Number of subjects: 107
Study 25070546 — intervention group
Group type: COMPARATOR
Intervention: Weekly paclitaxel (wPxl; 80 mg/m(2)/week ×6 with 2‐week break) plus placebo (P)
Number of subjects: 107
Study 25070546 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups (wPxl + S and wPxl + P) with taxane interval ≥6 months/no prior taxane
Number of subjects: 107
Study 23347605 — intervention group
Group type: COMPARATOR
Intervention: Clomiphene citrate 100mg daily for 5 days
Number of subjects: 100
Study 23347605 — intervention group
Group type: EXPERIMENTAL
Intervention: Cimicifuga racimosa 20mg daily for 10 days
Number of subjects: 100